BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2362633)

  • 1. Reduction of proteinuria by adrenalectomy and its restoration by glucocorticoids in rats bearing functioning pituitary tumor.
    Maeda T; Furukawa I; Suzuki T; Mori H
    Nephron; 1990; 55(2):181-6. PubMed ID: 2362633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria induced by transplantable rat pituitary tumor MtT SA5. Model for homologous protein-overload proteinuria.
    Mori H; Yamashita H; Nakanishi C; Koizumi K; Makino S; Kishimoto Y; Hayashi Y
    Lab Invest; 1986 Jun; 54(6):636-44. PubMed ID: 3713138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in insulin binding induced by changes in vivo in the levels of glucocorticoids and growth hormone.
    Kahn CR; Goldfine ID; Neville DM; De Meyts P
    Endocrinology; 1978 Oct; 103(4):1054-66. PubMed ID: 217665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone Enhances the Beneficial Effects of Glucocorticoids in Experimental Nephrotic Syndrome.
    Agrawal S; Chanley MA; Westbrook D; Nie X; Kitao T; Guess AJ; Benndorf R; Hidalgo G; Smoyer WE
    Sci Rep; 2016 May; 6():24392. PubMed ID: 27142691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mineralocorticoids and glucocorticoids on compensatory adrenal growth in rats.
    Phillips R; Crock C; Funder J
    Am J Physiol; 1985 Apr; 248(4 Pt 1):E450-6. PubMed ID: 3985143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent interaction between glucocorticoids and growth hormone-releasing factor in vivo.
    Wehrenberg WB; Baird A; Ling N
    Science; 1983 Aug; 221(4610):556-8. PubMed ID: 6408735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined therapy with estrogen and testosterone eliminates the aggravating effect of estrogen replacement therapy on glomerular injury in hypercholesterolemic female Imai rats.
    Ikeda Y; Sakemi T; Tomiyoshi Y; Miyazono M
    Kidney Blood Press Res; 2000; 23(1):27-34. PubMed ID: 10567851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged hypothermia after phenobarbital-induced anesthesia in adrenalectomized rats.
    Janocko L; Mycek MJ
    Pharmacol Biochem Behav; 1986 Jun; 24(6):1651-8. PubMed ID: 3737633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal pathology in rats bearing tumour-secreting growth hormone.
    Kawaguchi H; Itoh K; Mori H; Hayashi Y; Makino S
    Pediatr Nephrol; 1991 Jul; 5(4):533-8. PubMed ID: 1911134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid regulation of growth hormone (GH) secretagogue-induced growth responses and GH secretagogue receptor expression in the rat.
    Thomas GB; Bennett PA; Carmignac DF; Robinson IC
    Growth Horm IGF Res; 2000 Feb; 10(1):45-52. PubMed ID: 10753592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional and morphological characteristics of transplantable rat pituitary tumors established in nude mice.
    Makino S; Mori H; Koizumi K; Yamashita H; Hayashi Y; Aono T; Matsumoto K
    Cancer Res; 1984 Oct; 44(10):4487-95. PubMed ID: 6540621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
    van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
    Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression of the receptor for growth-hormone-releasing hormone is physiologically regulated by glucocorticoids and estrogen.
    Lam KS; Lee MF; Tam SP; Srivastava G
    Neuroendocrinology; 1996 Jun; 63(6):475-80. PubMed ID: 8793888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury.
    Remuzzi A; Puntorieri S; Alfano M; Macconi D; Abbate M; Bertani T; Remuzzi G
    Lab Invest; 1992 Nov; 67(5):572-9. PubMed ID: 1434536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of hypothalamic and pituitary corticotropin-releasing hormone receptor messenger ribonucleic acid by adrenalectomy and glucocorticoids.
    Luo X; Kiss A; Rabadan-Diehl C; Aguilera G
    Endocrinology; 1995 Sep; 136(9):3877-83. PubMed ID: 7649095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoid-like actions of medroxyprogesterone acetate upon MtTW15 rat mammosomatotropic pituitary tumors.
    Winneker RC; Parsons JA
    Endocrinology; 1981 Jul; 109(1):99-105. PubMed ID: 6453713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of renin secretion in conscious adrenalectomized rats with glucocorticoid-induced hypertension.
    Burris JF; Waeber B; Nussberger J; Brunner HR
    Arch Int Pharmacodyn Ther; 1986 Apr; 280(2):292-301. PubMed ID: 3521516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of pituitary insulin-like growth factor-I messenger ribonucleic acid levels in rats harboring somatomammotropic tumors: implications for growth hormone autoregulation.
    Fagin JA; Brown A; Melmed S
    Endocrinology; 1988 May; 122(5):2204-10. PubMed ID: 3359980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Divergent effects of glucocorticoid on the gene expression of vasoactive intestinal peptide in the rat cerebral cortex and pituitary.
    Lam KS; Srivastava G; Tam SP
    Neuroendocrinology; 1992 Jul; 56(1):32-7. PubMed ID: 1641071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.